AIDS care and treatment in Sub-Saharan Africa: implementation ethics.
With the advent of new AIDS treatment initiatives such as the World Health Organization's "3 by 5" program and the United States' "President's Emergency Plan for AIDS Relief," the ethical questions about AIDS care in the developing world have changed. No longer are they fundamentally about the conduct of research; now, we must turn our attention to developing treatment programs. In particular, we must think about how to spread limited treatment resources among the vast reservoir of people who need them.
Rennie
Stuart
S
Department of Dental Ecology, University of North Carolina, Chapel Hill, USA.
Behets
Frieda
F
D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D017954:Africa South of the Sahara / Q000453:epidemiology; D019380:Anti-HIV Agents / Q000627:therapeutic use; D018849:Controlled Clinical Trials as Topic / Q000941:ethics; D032984:Ethics, Research; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy; D015276:Health Care Rationing / Q000941:ethics*; D006297:Health Services Accessibility / Q000941:ethics; D006801:Humans; D007391:International Cooperation; D008403:Mass Screening; D008507:Medically Underserved Area; D020380:Needs Assessment / Q000941:ethics*; D016730:Program Development; D014454:Uganda; D014481:United States; D014944:World Health Organization; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D015215:Zidovudine